Literature DB >> 14535952

The first and third intracellular loops together with the carboxy terminal tail of the delta-opioid receptor contribute toward functional interaction with Galpha16.

Anthony S L Chan1, Ping Y Law, Horace H Loh, Peter N N Ho, Wai-Man Wu, Joy S C Chan, Yung H Wong.   

Abstract

Opioid peptides exert their regulatory effects on both central and peripheral nervous systems via multiple opioid receptors that are linked to seemingly identical sets of guanine nucleotide-binding regulatory proteins (G proteins). In contrast to the mu-opioid receptor, the delta-opioid receptor can efficiently stimulate phospholipase C via G16. We used a series of mu/delta-opioid receptor chimeras to examine the involvement of intracellular receptor domains in the recognition of G16. After ascertaining that the chimeras can bind opioid ligands with high affinity and elicit inhibition of adenylyl cyclase, COS-7 cells were cotransfected with cDNAs encoding Galpha16 and a mu/delta-opioid receptor chimera and assayed for [D-Ala2,D-Leu5]enkephalin-induced stimulation of phospholipase C. Our results indicate that (i) the carboxy terminal tail of the delta-opioid receptor is necessary but insufficient for conferring coupling to Galpha16, (ii) the third inner loop together with the carboxy terminal tail of the delta-opioid receptor can provide sufficient contact domains for Galpha16, and (iii) the first inner loop of the delta-opioid receptor, in particular Leu80, as well as the fifth transmembrane domain and/or the third extracellular loop may also contribute in defining the fidelity of interaction between the delta-opioid receptor and Galpha16. These results indicate that efficient coupling of the delta-opioid receptor to Galpha16 requires the participation of most of the intracellular regions, including the first intracellular loop.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14535952     DOI: 10.1046/j.1471-4159.2003.02040.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

Review 1.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

2.  Receptor antagonism/agonism can be uncoupled from pharmacoperone activity.

Authors:  Jo Ann Janovick; Timothy P Spicer; Emery Smith; Thomas D Bannister; Terry Kenakin; Louis Scampavia; P Michael Conn
Journal:  Mol Cell Endocrinol       Date:  2016-07-04       Impact factor: 4.102

Review 3.  The delta opioid receptor tool box.

Authors:  Ana Vicente-Sanchez; Laura Segura; Amynah A Pradhan
Journal:  Neuroscience       Date:  2016-06-24       Impact factor: 3.590

4.  Identification of a stretch of six divergent amino acids on the alpha5 helix of Galpha16 as a major determinant of the promiscuity and efficiency of receptor coupling.

Authors:  Maurice K C Ho; Jasmine H P Chan; Cecilia S S Wong; Yung H Wong
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

5.  Modeling and simulation of the human delta opioid receptor.

Authors:  Mahalaxmi Aburi; Paul E Smith
Journal:  Protein Sci       Date:  2004-07-06       Impact factor: 6.725

6.  Protein kinase Cε is required for spinal analgesic synergy between delta opioid and alpha-2A adrenergic receptor agonist pairs.

Authors:  Daniel J Schuster; Kelley F Kitto; Aaron C Overland; Robert O Messing; Laura S Stone; Carolyn A Fairbanks; George L Wilcox
Journal:  J Neurosci       Date:  2013-08-14       Impact factor: 6.167

Review 7.  Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives.

Authors:  Marta Sobczak; Maciej Sałaga; Martin A Storr; Jakub Fichna
Journal:  J Gastroenterol       Date:  2013-02-09       Impact factor: 7.527

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.